The First AI Drug Prescriber

JAMA 2026

View at publisher
Authors: Daniel G. Aaron, Christopher T. Robertson
DOI: 10.1001/jama.2026.3533
Cited by: 5
References: 7

Abstract

This Viewpoint explores the entry of AI into clinical care, the role of the US Food and Drug Administration, and the associated legal, public health, and medical implications.

Fields of Study & Subjects

Artificial Intelligence in Healthcare and Education Law AI and Intellectual Property Ethics and Social Impacts of AI

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
335
Issue
18
Pages
1567–1567
Publication date
13 April 2026
Language
EN